Bio-Matrix Scientific Group

Company Website

1649 Dartmouth
Chula Vista, CA 91913

Sourcebook Data

View all the companies in Biomed & Biotech Firms - Publicly Traded*

Bio-Matrix Scientific Group

Market Cap as of 7/03/2014

$9,443,344

Market Cap as of 07/02/2013

$5,595,237

Market Cap as of 06/26/2012

$267,102

Market Cap as of 01/04/2012

$151,598

Market Cap as of 06/20/2011

$938,460

Market Cap as of 01/06/2011

$2,464,141

Exchange and Ticker Symbol

OTC US: BMSN

Fields of Research

Focuses on the development of regenerative medicine therapies and tools

Major Products

Stem cell technologies

Stocks

Company Trade Data

Stock Symbol Close Change Volume 52-Week
Chg %Chg High Low
BMSN
0.00
  0.00  
+ 0.00%
2,766,000,000
0.01
0.00

Executives

David Koos

  • Chairman
  • Chief Executive Officer
  • President

Related News

Articles

Regen BioPharma files FDA application for anemia drug

Regen BioPharma announced Tuesday the filing of an Investigational New Drug (IND) application with the Food and Drug Administration to initiate clinical trials assessing the company's HemaXellerate I stem cell drug in patients with drug-refractory aplastic anemia.

Similar Companies

Biological Product (except Diagnostic) Manufacturing325414
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES2836
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers423450
MEDICAL, DENTAL, AND HOSPITAL EQUIPMENT AND SUPPLIES5047
Subscribe Today!